Cargando…
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
We have previously used composite reference standards and latent class analysis (LCA) to evaluate the performance of laboratory assays in the presence of tarnished gold standards. Here, we apply these techniques to repeated, cross-sectional study of Canadian blood donors, whose sera underwent parall...
Autores principales: | Tuite, Ashleigh R., Fisman, David, Abe, Kento T., Rathod, Bhavisha, Pasculescu, Adrian, Colwill, Karen, Gingras, Anne-Claude, Yi, Qi-Long, O’Brien, Sheila F., Drews, Steven J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865569/ https://www.ncbi.nlm.nih.gov/pubmed/35196819 http://dx.doi.org/10.1128/spectrum.02563-21 |
Ejemplares similares
-
A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
por: Abe, Kento T., et al.
Publicado: (2022) -
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
por: Lin, Yi-Chan J., et al.
Publicado: (2023) -
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard
por: Saeed, Sahar, et al.
Publicado: (2021) -
Resistance of SARS‐CoV‐2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020
por: Drews, Steven J., et al.
Publicado: (2021) -
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022)